Keywords
Hypertension
Risk Factors
Outcomes
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To carry out a comparative analysis of the risk factors and clinical outcomes of patients treated at a university hospital in the northeast of the country. Methods: A cross-sectional descriptive study was carried out by analyzing 23 medical records of patients diagnosed with hypertension and diabetes mellitus admitted to the university hospital between March 2018 and March 2023. Results: 73.91% of inpatients were male and 47.82% were over 70 years old. With regard to the sociodemographic profile, a large proportion (34.78%) had incomplete primary school education. It was observed that 26.08% of the patients had diabetic foot and 21.73% had vascular complications. Clinical data revealed that 13.04% of the patients had undergone amputations as a result of irreversible ulcerations associated with the diabetic foot. As for laboratory tests, it was observed that of 17 patients with glycated hemoglobin (HbA1c) records, 14 had values above the limit, while only 2 individuals, out of a total of 10 with blood pressure records, exceeded the maximum value. Conclusion: The most common outcomes were diabetic foot, atherosclerosis and infection in amputated limbs. Common aspects such as age and gender emerged as prominent risk factors.
References
AMERICAN DIABETES ASSOCIATION (ADA). Standards of Medical Care in Diabetes. 2022. Disponível em: https://diabetes.org/. Acessado em: 26 de março de 2023.
ANDRADE JU, et al. Adesão ao regime terapêutico de pacientes com diabetes Mellitus: análise de atividades de autocuidado. Brazilian Journal of Development, 2020; 6(7): 48115-48129.
BEASON-HELD LL, et al. Longitudinal Changes in Cerebral Blood Flow in the Older Hypertensive Brain. Stroke, 2007; 38(6): 1766–1773.
BRASIL. Ministério da Saúde. 2020. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/2020/maio/diabetes-hipertensao-e-obesidade-avancam-entre-os-brasileiros-3. Acessado em: 03 de dezembro de 2023.
BRASIL. Ministério da Saúde. Definição – Hipertensão Arterial Sistêmica (HAS) no adulto, 2023. Disponível em: https://linhasdecuidado.saude.gov.br/portal/hipertensao-arterial-sistemica-(HAS)-no-adulto/definicao-hipertensao-arterial-sistemica-has-no-adulto/. Acessado em: 01 de abril de 2023.
BRENNER BM, et al. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. New England Journal of Medicine, 2001; 345(12): 861–869.
CHERBUIN N, et al. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology, 2012; 79(10): 1019–1026.
CRUICKSHANK K, et al. Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance. Circulation, 2002; 106(16): 2085–2090.
CUNHA RC, et al. Burden of diabetes mellitus and hypertension overuse in a Brazilian public primary care setting: A cross-sectional study. BMC Health Services Research, 2021; 21(1): 1-9.
ELKINS J, et al. Pre-existing hypertension and the impact of stroke on cognitive function. Annals of Neurology, 2005; 58(1): 68–74.
INTERNATIONAL DIABETES FEDERATION (IDF). IDF Diabetes Atlas. 10th ed. Brussels, Belgium: IDF; 2021.
IRIE F, et al. Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE ε4. Archives of Neurology, 2008; 65(1).
LEWIS EJ, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England journal of medicine, 2001; 345(12): 851–60.
LI S, et al. The prevalence and temporal trends of hypertension, diabetes mellitus and dyslipidemia in Chinese adults: A cross-sectional study from 2010 to 2015. Lipids in Health and Disease, 2021; 20(1): 1-11.
LIPSKY BA, et al. 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clinical Infectious Diseases, 2012; 54(12): e132–e173.
LIVINGSTON G, et al. Dementia prevention, intervention, and Care. The Lancet, 2017; 390(10113): 2673–2734.
NATHAN DM, et al. Translating the A1C Assay Into Estimated Average Glucose Values. Diabetes Care, 2008; 31(8): 1473–1478.
RAINA P, et al. Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. Annals of Internal Medicine, 2008; 148(5): 379.
SCHMIDT MI, et al. Prevalence, awareness, treatment, and control of high blood pressure in Brazil. American Journal of Hypertension, 2011; 24(3): 361-368.
SOCIEDADE BRASILEIRA DE DIABETES (SBD). Diretrizes da Sociedade Brasileira de Diabetes. 2023. Disponível em: https://diretriz.diabetes.org.br/. Acessado em: 26 de março de 2023.
SOCIEDADE BRASILEIRA DE HIPERTENSÃO (SBH). Hipertensão arterial. 2022. Disponível em: http://www.sbh.org.br/hipertensao-arterial/. Acessado em: 26 de março de 2023.
VERDELHO A, et al. White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study. Neurology, 2010; 75(2): 160–167.
VIAZZI F, et al. Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes. Journal of Hypertension, 2019; 37(4): 805–813.
WANG LY, et al. Blood Pressure and Brain Injury in Older Adults: Findings from a Community-Based Autopsy Study. Journal of the American Geriatrics Society, 2009; 57(11): 1975–1981.
ZHANG Y, et al. Prevalence of hypertension and diabetes mellitus in various regions of the world: A systematic review and meta-analysis. Medicine, 2021; 100(33): e26776.